Updated October 2003

Gerald T. Keusch, M.D.
Director
Associate Director for International Research, NIH

Keusch GT. The History of Nutrition: Malnutrition, Infection and Immunity. J Nutr. 133:336S-340S, 2003.

Keusch GT, Medlin CA. Tapping the power of small institutions. Nature 422: 561-562, 2003.

Keusch GT, Nugent RA. The role of intellectual property and licensing in promoting research in international health: perspectives from a public sector biomedical research agency. CMH Working Paper Series, Paper No. WG2:7, Commission on Macroeconomics and Health, World Health Organization, Geneva, January, 2002.

Breman JG, Egan A, Keusch GT. The intolerable burden of malaria: a new look at the numbers. Am J Trop Med Hyg 64(1-2 Suppl):iv-vii, 2001.

Keusch GT. Dietary supplements, botanicals, and probiotics: hope or hype? Nutr Clin Care 4:1-3, 2001.

Keusch GT. Toxin-associated Gastro-intestinal Disease: A Clinical Overview. In: Molecular Medical Microbiology. Academic Press, New York, 2001

Keusch GT. Superficial Gastro-intestinal Infections: A Clinical Overview. In: Molecular Medical Microbiology. Academic Press, New York, 2001

Keusch GT. Shigella. In: Molecular Medical Microbiology. Academic Press, New York, 2001

Keusch GT. Systemic Gastro-intestinal Infections: A Clinical Overview. In: Molecular Medical Microbiology. Academic Press, New York, 2001

Keusch GT.  Dietary supplements, botanicals, and probiotics: hope or hype?  Nutr Clin Care 4:1-3, 2001.

Breman JG, Egan A, Keusch GT.  The intolerable burden of malaria: a new look at the numbers.  Am J Trop Med Hyg 64(1-2 Suppl):iv-vii, 2001.

Kang G, Pulimood AB, Koshi R, Hull A, Acheson D, Rajan P, Keusch GT, Mathan VI, Mathan MM.  A Monkey Model for Enterohemorrhagic Escherichia coli Infection.  J Infect Dis 184:206-10, 2001.

Keusch GT. The National Institutes of Health agenda for international research in micronutrient nutrition and infection interactions. J. Infect. Dis. 182 (Suppl 1):S139-S142, 2000.

Keusch GT. The potential impact of nutritional change on the global burden of viral disease. Nutr Rev 58 (Pt 2):S55-S62, 2000.

Keusch GT.  The potential impact of nutritional change on the global burden of viral disease.  Nutr Rev 58 (Pt 2):S55-S62, 2000.

Acheson DW, Kane AV, Keusch GT.  Shiga toxins.  Methods Mol. Biol. 145:41-63, 2000.

Keusch GT.  The National Institutes of Health agenda for international research in micronutrient nutrition and infection interactions.  J. Infect. Dis. 182 (Suppl 1):S139-S142, 2000.

Cevallos AM, Bhat, N, Verdon R, Hamer, DH, Stein B, Tzipori S, Pereira M, Keusch GT, Ward HD.  Mediation of C. parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody.  Infect Immun 68:5167-5175, 2000.

Zhang Z, McDaniel AD, Wolf LE, Keusch GT, Waldor MK, Acheson DWK.  Quinolone antibiotics induces Shiga toxin-encoding bacteriophages, toxin production and death in mice.  Infect Immun 181:664-670, 1999.

Hurley BP, Jacewicz M, Thorpe CM, Lincicome LL, King AJ, Keusch GT, Acheson DWK. Shiga toxins 1 and 2 translocate differently across polarized intestinal epithelium.  Infect Immun 67:6670-6677, 1999.

Thorpe CM, Hurley BP, Lincicome L, Jacewicz M, Keusch GT, Acheson DWK.  Shiga toxins stimulate secretion of IL-8 from intestinal epithelial cells by altering regulation of cell processes.  Infect Immun 67;5985-5993, 1999.

Thorpe CM, Flaumenhaft R, Hurley B, Jacewicz M, Acheson DWK, Keusch GT. Shiga toxins do not directly stimulate alpha-granule secretion or enhance aggregation of human platelets.  Acta Haematolgia,  102:51-55, 1999.

Krishnan S, Ramakrishna BS, Keusch GT, Pulimood A, Mathan M.  Effect of Shiga toxin on NaCl transport in rat distal colon.  Scand J Gastroenterology 34:777-783, 1999.

King AJ, Sundaram S, Cendoroglo M, Acheson DWK, Keusch GT.  Shiga toxin induces superoxide production in polymorphonuclear cells with subsequent impairment of phagocytosis and responsiveness to phorbol esters.  J Infect Dis 179:503-507, 1999.

Jacewicz M, Acheson DWK, Binion DG, West GA, Lincicome L, Fiocchi C, Keusch GT.  Responses of human intestinal microvascular endothelial cells to Shiga toxins 1 and 2 and pathogenesis of hemorrhagic colitis.   Infect Immun 67:1439-1444, 1999.

Kotler DP, Thea DM, Heo M, Allison DB, Engelson ES, Wang J, Pierson RN Jr, St Louis M, Keusch GT.  Relative influence of sex, race, environment, and HIV infection on body composition in adults.  Am J Clin Nutr 69:432-439, 1999.

Book Chapters

Kaplan S, Keusch GT Diarrhea- and dysentery-causing Escherichia coli. In: Textbook of Pediatric Infectious Diseases. Saunders, Philadelphia, 2003

Gonzales B, Keusch GT, Vellejo JG. Cholera. In: Textbook of Pediatric Infectious Diseases. Saunders, Philadelphia, 2003

Keusch GT, Bart KJ. Miller M. Immunization Principles and Vaccine Use. In: Harrison's Principles of Internal Medicine, 16^{th Edition. McGraw-Hill, New York, In Press}

Keusch GT, Kopecko D. Shigellosis. . In: Harrison's Principles of Internal Medicine, 16th Edition. McGraw-Hill, New York, In Press

Keusch GT.  Waldor, MK.  In: Harrison's Principles of Internal Medicine, 15^th Edition.  McGraw-Hill, New York, 2001.

Keusch GT.  Shigellosis. .  In: Harrison's Principles of Internal Medicine, 15^th Edition.  McGraw-Hill, New York, 2001.

Keusch GT, Bart KJ.  Immunization Principles and Vaccine Use.  In: Harrison's Principles of Internal Medicine, 15^th Edition.  McGraw-Hill, New York, 2001.

Keusch GT.  Tropical Sprue.  In: Infectious Diseases, Armstrong D, Cohen J, Eds.  Mosby, London. 1999. 

Keusch GT.  Host Response to Infection.  In: Infectious Diseases, Armstrong D, Cohen J, Eds.  Mosby, London. 1999. 

Krogstad D, Maguire J, Walker J, Weller P, Eds.  Churchill Livingstone, NY. 1999.

Keusch GT.  Nutrition and Infection.  In: Tropical Infectious Diseases, Guerrant RL, Krogstad D, Maguire J, Walker J, Weller P, Eds.  Churchill Livingstone, NY.  1999.

 

Sharon Hrynkow, Ph.D.
Deputy Director, Fogarty International Center

Opinion/Outreach:

Hrynkow, Sharon H., Primack, Aron and Bridbord, Kenneth.  Paradigms and Progress in Building Research Capacity in International Environmental Health.  International Journal Hygiene Environmental Health, 206, 1-10, 2003.

Hrynkow, Sharon H., Gust, Steve.  Cooperation in International Research: Fogarty International Center and the National Institute on Drug Abuse, NIDA INVEST Newsletter Spring/Summer 2003.

Hrynkow, S., Chair, AAAS Report on Central Asia: US Foreign Policy and Science/Technology, Report of Health Working Group, AAAS publication, 2003.

Hrynkow, Sharon H., Keusch, Gerald.  Building on Success, Responding to Need:  The Fogarty International Center Launches Clinical, Operational and Health Services Research and Research Training Programs.  Global Health Link, 2002.

Hrynkow, Sharon H., Keusch, Gerald.  Fogarty Seeds Research Grants to Help Developing Countries.  Global Health Link., 2002.

 

Joel Breman, M.D., D.T.P.H.
Senior Scientific Advisor, Division of International Epidemiology and Population Studies
Program Officer, Division of International Training and Research

Breman JG, Arita A, Fenner F. Preventing the return of smallpox. N Engl J Med 2003;348:457-60.

Albert MR, Ostheimer KG, Liewehr DJ, Steinberg SM, Breman JG.  Smallpox manifestations and survival during the Boston epidemic of 1901-1903.  Ann Int Med 2002 (in press).

Breman JG, Henderson DA.  Smallpox Diagnosis and management.  N Engl J Med 2002; 346:7300-08.

Borio L, Inglesby T, Peters CJ, Schmaljohn AK, Hughes JM, Jahrling PB, Ksiazek T, Johnson KM, Meyerhoff A, O’Toole T, Ascher MS, Bartlett J, Breman JG, Eitzen EM Jr, Hamburg M, Hauer J, Henderson DA, Johnson RT, Kwik G, Layton M, Lillibridge S, Nabel GJ, Osterholm MT, Perl TM, Russell P, Tonat K.  Hemorrhagic fever viruses as biological weapons: medical and public health management.  JAMA 2002;287:2391-405.

Breman JG, LeDuc J.  International partnerships in infectious diseases research, training and control.  Emerg Inf Dis 2001;7:542-3.

Murphy SC, Breman JG.  Gaps in the childhood malaria burden in Africa:  cerebral malaria, neurologic sequelae, anemia, respiratory distress, hypoglycemia and complications of pregnancy.  Am J Trop Med Hyg 2001;64 (Suppl 1-2) 57-67.

Breman JG.  The ears of the hippopotamus: manifestations, determinants and estimates of the malaria burden.  Am J Trop Med Hyg 2001;64 (Suppl 1-2):1-11.  

Breman JG, Egan A, Keusch GT.  Introduction and summary:  The intolerable burden of malaria:  a new look at the numbers.  Am J Trop Med Hyg 2001;64 (Suppl 1-2):iv - vii. 

Breman JG.  Guest editor’s page: Objectives and acknowledgments.  Am J Trop Med Hyg 2001;64 (Suppl 1-2):i. 

Special Symposium on "The Intolerable Burden of Malaria: A New Look at the Numbers", Supplement to the American Journal of Tropical Medicine and Hygiene January-February 2001; 64 (Suppl 1-2):1-106

Albert MR, Ostheimer KG, Breman JG.  The last smallpox epidemic in Boston and the vaccination controversy, 1901-1903.  N Eng J Med 2001;344:375-9.

Breman JG.  Malaria control stymied in 2010, mastered in 2025.  Bull World Health Organ 2000;78:1450-2.

Breman JG, Arita A, Fenner F. Preventing the return of smallpox. N Engl J Med 2003;348:457-60

Book Chapters, Monographs, Proceedings:

White NJ, Breman JG. Malaria and Babesiosis. In Harrisons Principles of Internal Medicine, sixteenth edition, D Kasper, E Braunwald, AS Fauci, SL Hauser, DL Longo, JL Jameson, eds, McGraw Hill Co, New York (in press, 2003).

Albert MR, Breman JG. Smallpox. In Conn’s Current Therapy, RE Rakel, ET Bope, eds., WB Saunders Co., Philadelphia (in press, 2003).

Albert MR, Lucey DR, Breman JG. Smallpox. In Hospital Epidemiology and Infection Control, third edition, G Mayhall, ed. Lippincott, Williams and Wilkins, New York (in press, 2003).

Albert MR, Breman JG.  Smallpox.  In Conn’s Current Therapy, RE Rakel, ET Bope, eds., WB Saunders Co., Philadelphia (in press, 2003).  

Albert MR, Lucey DR, Breman JG.  Smallpox.  In Hospital Epidemiology and Infection Control, third edition, G Mayhall, ed.  Lippincott, Williams and Wilkins, New York (in press, 2003). 

White NJ, Breman JG.  Malaria.  In Harrisons Principles of Internal Medicine, sixteenth edition, D Kasper, E Braunwald, AS Fauci, SL Hausen, DL Longe, JL Jameson, eds, McGraw Hill Col, New York (in press, 2003). 

Albert MR, Ostheimer KG, Llewehr DJ, Steinberg SM, Breman JG.  Smallpox Manifestations and Survival during the Boston Epidemic of 1901 to 1903.  In Annals of Internal Medicine, Vol. 137, No. 12, Dec. 17 2002.   

Breman JG, Henderson DA.  Diagnosis and Management of Smallpox.  In The New England Journal of Medicine, Vol. 346:1300-1308, 2002.   

White NJ, Breman JG.  Malaria and babesiosis caused by red blood cell parasites.  In:  Harrisons Principles of Internal Medicine, fifteenth edition, E Braunwald, AS Fauci, DL Kasper, SL Hauser, DL Longo, JL Jameson, eds, McGraw-Hill Co., New York, 2001:  1203-1213. 

Breman JG. Monkeypox:  an emerging infection for humans?  In:  Emerging Infections 4, WM Scheld, WA Craig, JM Hughes, eds.  American Society for Microbiology, Washington, D.C., 2000:45-67. 

Breman JG. Smallpox.  In: Hunter’s Tropical Medicine and Emerging Infectious Diseases, eighth edition, GT Strickland, ed., WB Saunders Co., Philadelphia: WB Saunders Company, 2000:207-210. 

Redd SC, Breman JG.  Measles.  In:  Hunter’s Tropical Medicine and Emerging Infectious Diseases, eighth edition, GT Strickland, ed., WB Saunders Co., Philadelphia: WB Saunders Company, 2000:199-207.  

Lucey D, Breman JG.  Smallpox.  In Bioterror:  The Weaponization of Infectious Diseases.  LI Lutwick, SM Lutwick, eds, Humana press, Totowa, New Jersey (in press, 2004)

Abstract

Rosen J, Breman JG, Miller, MA. Malaria Immunodepression and the Serologic Response to Measles and Diphtheria-Tetanus-Pertussis Vaccine. American Society of Tropical Medicine and Hygiene meeting, Philadelphia, PA.  December 2003.

 

Jonathan Dushoff, Ph.D.
Research Scientist, Division of International Epidemiology and Population Studies

J. Dushoff, L. Worden, J. Keymer, and S. Levin. Metapopulations, community assembly, and scale invariance in aspect space. Theor. Popul. Biol.,62:329:338, 2002.

 J. B. Plotkin, J. Dushoff, and S. A. Levin. Hemagglutinin sequence clusters and the antigenic evolution of infuenza a virus. Proc. Natl. Acad. Sci. USA, 99:6263:6268, 2002.

G. Dwyer, J. Dushoff, J. S. Elkinton, J. P. Burand, and S. A. Levin. Host heterogeneity in susceptibility: Lessons from an insect virus. In Ulf J. Dieckmann, Hans Metz, Maurice Sabelis, and Karl Sigmund, editors, Virulence Management: The Adaptive Dynamics of Pathogen-Host Interactions.  Cambridge U. Press, Cambridge, 2002.  

S. A. Levin, J. Dushoff, and J. E. Keymer. Community assembly and the emergence of ecosystem pattern. Sci. Mar., 65(Suppl. 2):171:179, 2001.

Jon Norberg, Dennis P. Swaney, Jonathan Dushoff, Juan Lin, Renato Casagrandi, and Simon A. Levin. Phenotypic diversity and ecosystem functioning in changing environments: A theoretical framework. Proc. Natl. Acad. Sci. USA, 98:11376:11381, 2001.

J. Dushoff and G. Dwyer. Evaluating the risks of engineered viruses: Modelling pathogen competition. Ecol. Appl., 11:1602:1609, 2001.

G. Dwyer, J. Dushoff, J. S. Elkinton, and S. A. Levin. Pathogen-driven out-breaks in forest defoliators revisited: Building models from experimental data. Am. Nat., 156:105:120, 2000.

J. Dushoff. Carrying capacity and demographic stochasticity: Scaling behavior of the stochastic logistic model. Theor. Pop. Biol., 57:59:65, 2000.

Dushoff. Host heterogeneity and disease endemicity: A moment-based approach. Theor. Pop. Biol., 56:325:335, 1999.

A. P. Kinzig, S. A. Levin, J. Dushoff, and S. Pacala. Limiting similarity and species packing in competition-colonization models. Am. Nat., 153:371:383, 1999.

J. Molofsky, R. Durrett, J. Dushoff, D. Griffeath, and S. Levin. Local frequency-dependence and global coexistence. Theor. Pop. Biol., 55:270: 282, 1999.

 

Pierce Gardner, M.D.
Senior Advisory for Clinical Research and Training

Gardner P. A Need to Update and Revise the Pneumococcal Vaccine Recommendations for Adults. Ann Intern Med. 2003;138:999-1000.

Halsell JS, Riddle JR, Atwood JE, Gardner P, Shope R,et al. Myocarditis Following Smallpox Vaccination Among Vaccinia-naive US Military Personnel. JAMA. 2003;289:3283-3289.

 

Flora Katz, Ph.D.
Program Officer, Division of International Training and Research

Rosenthal, J.P. and Katz, F.N. (2003). Natural Products Research Partnerships with Multiple Objectives in Global Biodiversity Hotspots: Nine Years of the ICBG Program in Microbial Diversity and Bioprospecting, Alan T. Bull (ed), ASM Press. In press.

Buckles GR, Rauskolb C, Villano JL, and Katz FN (2001). four-jointed interacts with dachs, abelson and enabled and feeds back onto the Notch pathway to affect growth and segmentation in the Drosophila leg. Development 128, 3533-3542.

 

Richard M. Krause, M.D.
Senior Scientific Advisor, Division of Advanced Studies and Policy Analysis

Krause, RM, Evolving microbes and re-emerging streptococcal disease. Published by Elsevier Science, Clin Lab Med 22 (2002), 835-848.

Krause, RM., A Half Century of Streptococcal Research:   Then & Now, Based on a lecture given at the opening plenary session of the XV Lancefield International Symposium on Streptococci and Streptococcal Diseases, Goa, India, October 7, 2002.  Published by Indian J Med Res 115, June 2002, pp 215-241.

Krause, RM., The Role of NIH in Shaping Biomedical Research in the U.S., and the Spirit of Academic Entrepreneurship, Lecture delivered at the Symposium “Biomedical Research for Medicine in the New Millennium: The Roles of Academia, Industry and Government in Translational Research;”  Institute of Medical Science, The University of Tokyo, Tokyo, Japan, January 25, 2000.

Krause, Richard, Paul Ehrilich and O.T. Avery: Pathfinders in the Search for Immunity, presented at the 4^th European Conference on Vaccinology, Brighton, U.K., March 19, 1999, Vaccine, Volume 17, Supplement 3, October 1999.

Krause, Richard, Infectious Diseases in and Around the Pacific Basin, proceedings of the U.S.-Korea Forum on Emerging Infectious Diseases, National Center for Technology and Law, George Mason University Law School and the Korean Institute of Science and Technology, Arlington, Virginia, 1999.

Musser, James M., & Krause:  The Revival of Group A Streptococcal Diseases, With a Commentary on Staphylococcal Toxic Shock Syndrome, Emerging Infections, Krause, R.M., Editor Academic Press, Jan 1998

Krause, R.M., Introduction to Emerging Infectious Diseases; Stemming The Tide Emerging Infections, Editor, Academic Press, Jan 1998. 

Krause, Dimmock, and Morens:  Summary of Antibody Workshop: The Role of Humoral Immunity in the Treatment of Emerging and Extant Infectious Diseases J. of Infectious Dis., Vol 176, pp. 549-59, Sept 1997.

Krause, RM., Microbial factors in disease emergence illustrated by streptococcal toxic shock syndrome Federation of Microbiological Societies Fems Immunology and Medical Microbiology 18 (1997) pp. 227-232; Published by Elsevier Science.

Krause, RM., Metchnikoff and Syphilis Research during a Decade of Discovery, 1900-1910* ASM News, Vol 62, No. 6, pp. 307-310, 1996.

Krause, RM., Vaccines and Public Health:  the Use of Vaccines for Prevention of Infectious Diseases Jordan Report, 1996.
Krause, RM., Tuberculosis:  Romance to Reality to Resurgence, Cosmos 1996, Volume 6, pp71-77.

Krause, R.M., Reflections on the first decade of the HIV/AIDS pandemic:  opportunities and priorities for interventional behavioural research and interventions J. of STD & AIDS, Vol 7 (Suppl 2), pp. 47-51, 1996.

 

Jeanne McDermott, C.N.M., M.P.H., Ph.D.
Program Officer, Division of International Training and Research 

Ronsmans C, Campbell OM, McDermott J, Koblinsky M. Questioning the indicators of need for obstetric care. Bull World Health Organ. 80(4):317-24. Review, 2002

Walker D, McDermott JM, Fox-Rushby J, Tanjung M, Nadjib M, Widiatmoko D,Achadi E. An economic analysis of midwifery training programmes in South Kalimantan,Indonesia. Bull World Health Organ.;80(1):47-55, 2002.

Ronsmans C, Endang A, Gunawan S, Zazri A, McDermott J, Koblinsky M, Marshall T. Evaluation of a comprehensive home-based midwifery programme in South Kalimantan, Indonesia. Trop Med Int Health. 6(10):799-810, 2001.

McDermott J, Beck D, Buffington ST, Annas J, Supratikto G, Prenggono D, Sri Ekonomi FM, Achadi E. Two models of in-service training to improve midwifery skills: how well do they work? J Midwifery Women’s Health. 46(4):217-25, 2001.

 

Ellis McKenzie, Ph.D.
Senior Research Scientist, Division of International Epidemiology and Population Studies

Rouzine, I.M., F.E. McKenzie. Link between immune response and parasite synchronization in malaria. Proceedings of the National Academy of Sciences USA (in press).

McKenzie, F.E., J.K. Baird, J.C. Beier, A.A. Lal, W.H. Bossert 2002. A biologic basis for integrated malaria control. American Journal of Tropical Medicine and Hygiene 67: 571-577.

McKenzie, F.E., G.M. Jeffery, W.E. Collins 2002. Plasmodium malariae infection boosts Plasmodium  falciparum gametocyte production. American Journal of Tropical Medicine and Hygiene 67: 411-414.

McKenzie, F.E., G.M. Jeffery, W.E. Collins 2002. Plasmodium vivax blood-stage dynamics.  Journal of Parasitology 88: 521-535.

McKenzie, F.E., M.U. Ferreira, J.K. Baird, G. Snounou, W.H. Bossert 2001. Meiotic recombination, cross-reactivity and persistence in Plasmodium falciparum. Evolution 55: 1299-1307.

McKenzie, F.E., G.F. Killeen, J.C. Beier, W.H. Bossert 2001.  Seasonality, parasite diversity and local extinctions in Plasmodium falciparum malaria.  Ecology 82: 2673-2681.

Mason, D.P., S. Krudsood, P. Wilairatana, P. Viriyavejakul, U. Silachamroon, W. Chokejindachai, P. Singhasivanon, S. Supavej, F.E. McKenzie, S.Looareesuwan 2001.  Can treatment of P. vivax lead to an unexpected appearance of falciparum malaria? Southeast Asian Journal of Tropical Medicine and Public Health 32: 57-63.

McKenzie, F.E., G.M. Jeffery, W.E. Collins 2001. Plasmodium malariae blood-stage dynamics. Journal of Parasitology 87: 626-637. 

McKenzie, FE 2001. What, if anything, is a strain? Trends in Parasitology 17: 569. 

McKenzie, F.E. 2001. Biodiversity strikes home. Trends in Parasitology 17: 263.

Killeen, G.F., F.E. McKenzie, B.D. Foy, C. Bogh, J.C. Beier 2001.  The availability of potential hosts as a determinant of feeding behaviours and malaria transmission intensity by African mosquito populations. Transactions of the Royal Society of Tropical Medicine and Hygiene 95: 469-476.

Killeen, G.F., F.E. McKenzie, B.D. Foy, C. Schieffelin, P.F. Billingsley, J.C. Beier 2000.  A simplified model for predicting malaria entomological inoculation rates based on entomological and parasitological parameters relevant to control.  American Journal of Tropical Medicine and Hygiene 62: 535-544.

Killeen, G.F., F.E. McKenzie, B.D. Foy, C. Schieffelin, P.F. Billingsley, J.C. Beier 2000.  The potential impacts of integrated malaria transmission control on entomological inoculation rate in highly endemic areas.  American Journal of Tropical Medicine and Hygiene 62: 545-551.

Leung, J.Y., F.E. McKenzie, A.M. Uglialoro, P.O. Flores-Villanueva, B.C. Sorkin, E.J. Yunis, D. 

Hartl, A.E. Goldfeld 2000.  Identification of phylogenetic footprints in primate tumor necrosis factor-apromoters.  Proceedings of the National Academy of Sciences USA 97: 6614-6618.

McKenzie, F.E. 2000.  Why model malaria? Parasitology Today 16: 511-516.  

McKenzie, F.E., R.C. Wong, W.H. Bossert 1999.  Discrete-event models of mixed-phenotype Plasmodium falciparum malaria.  Simulation 73: 213-217.

McKenzie, F.E., W.H. Bossert 1999.  Multispecies Plasmodium infections of humans.  Journal of  Parasitology 85: 12-18.

Mason, D.P., F.E. McKenzie 1999. Blood-stage dynamics and clinical implications of mixed Plasmodium vivax-Plasmodium falciparum infections.  American Journal of Tropical Medicine and Hygiene 61: 367-374.

Mason, D.P., F.E. McKenzie, W.H. Bossert 1999.  The blood-stage dynamics of mixed Plasmodium malariae-Plasmodium falciparum infections.  Journal of Theoretical Biology 198: 549-566. 

McKenzie, FE 1999. Reply. American Journal of Tropical Medicine and Hygiene 60: 517-518.

 

Mark A. Miller, M.D.
Director, Division of International Epidemiology and Population Studies
Associate Director for Research, Office of the Director

Miller M, Mintz, Eric,  Modelling Prevention Effectiveness:  An Interactive Model to Assess Public Health Prevention Programs.  In "A Practical Guide to Prevention Effectiveness:  Decision and Economic Analyses"  Haddix A (ed).  Atlanta:  US Department of Health and Human Services. 1994:67-173.

Exposure of passengers and flight crew to Mycobacterium tuberculosis on commercial aircraft, 1992-1995.  Morbidity and Mortality Weekly Report. 1995.  44:137-40.

Influenza and pneumococcal vaccination levels in persons > 65 years of age:  1973-1993.  Morbidity and Mortality Weekly Report.  1995:506-515.

The Cuba Neuropathy Field Investigation Team.   Epidemic optic neuropathy in Cuba:  Clinical characterization and risk factors.   New England Journal of Medicine.   1995;333:1176-82.

Miller M, Sutter R, Strebel P, Hadler S.  Cost-effectiveness of integrating inactivated poliomyelitis vaccine into the routine US vaccination schedule.  Journal of the American Medical Association.  1996;276:967-71.

 

Miller M, Valway S, Onoroto I. Tuberculosis risk after exposure on airplanes.  Tubercle and Lung Disease.  1996;77:414-9.

 

Glass RI, Bresee JS, Parashar U, Miller M, Gentsch JR.  Rotavirus vaccines at the threshold. Nature Medicine. 1997;3(12):1324-5.

 

The CVI Task Force on Strategic Planning.  The CVI Strategic Plan Managing Opportunity and Change:  A Vision of Vaccination for the 21^st Century.     Geneva:  The Children’s Vaccine Inititiative, 1997.

 

Miller MA.  An assessment of the value of haemophilus influenzae type B conjugate vaccine in Asia.  Pediatric Infectious Disease Journal 1998; Oct (Supl3):S152-9.

 

Miller MA, Redd SC, Hadler S, Hinman A.  A model to estimate the potential economic benefits of measles eradication for the United States.  Vaccine, 1998; 20:1917-22.

 

Miller MA.  Considerations for adding pneumonia and influenza vaccines to public health programs. Vaccine 1999; 17:S95-8.

 

Miller MA, Williams WW, Redd S.  Measles in the United States adult population 1985-1995.  American Journal of Preventive Medicine, 1999; 17:114--9.

 

Miller MA, Pisani E.  The cost of unsafe injections.  Bulletin of the World Health Organization, 1999; 77:808-11.

 

Miller MA , Wenger J, Rosenstien N, Perkins B.  Evaluation of meningococcal meningitis control strategies for the meningitis belt in Africa. Pediatrics Infectious Disease Journal 1999; 18:1051-9.

 

Miller MA.  Introducing a deterministic model to estimate global measles disease burden.  Journal of International Infectious Diseases, 2000; 4:14-20.

 

Miller MA, McCann L.   Policy analysis of the use of hepatitis b, Haemophilus influenzae type B-, Streptococcus pneumoniae- conjugate and rotavirus vaccines in national immunization schedules. Health Economics, 2000; 9:19-35.

 

Lieu TA, Ray GT, Black SB, Butler JC, Klein JO, Breiman RF, Miller MA Shinefield HR.  Projected cost-effectiveness of pneumococcal conjugate vaccination of healthy infants and young children. Journal of the American Medical Association, 2000; 283:1460-8.

 

Miller MA, Flanders, D.  A model to predict the probability of hepatitis b and Haemophilus influenzae type b vaccines into national immunization programs.  Vaccine, 2000; 18:2223-2230.

 

Miller MA, Kane M.  Routine hepatitis b immunization in India:  Cost-effectiveness assessment.  Indian Journal of Pediatrics, 2000; 67:299-300.

Freeman P, Miller M  Scientific Capacity building to improve population health:  Knowledge as a global public good.  WHO Commission on Macroeconomics and Health, Working Group 2:  Global Public Goods. http://www.cmhealth.org/docs/wg2_paper3.pdf, 2001.

Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI.  The global illness and deaths caused by rotavirus disease in children Emergine Infectious Disease. 2003; 9:565-72.

Bertozzi SM, Miller M.  Childhood diseases:  Comparing costs across countries, diarrhea, pneumonia and meningitis in India, the Philippines and Mexico (submitted).

 Reichert TA, Miller M, Simonsen L.  A simple approximation works surprisingly well : Adjusting the age distribution of monthly mortality data using only annual information on mortality by age.  (submitted).

Freeman P, Miller M, Robbins A, Sturke R, Nugent R. Investment in Scientific Capacity for Health:  A new place on development agendas (submitted).

 Reichert TA, Sharma A, Simonsen L, Saito R, Miller M. An excess of death in winter - A global problem:  Is there a single cause?  (submitted).

 

Simonsen L, Miller M, Reichert TA. The effectiveness of the US national vaccination program against influenza. (submitted).

 Miller M, Myer P, Simonsen L. The Risk of Inaction: Rotavirus vaccine in developing countries. (submitted).

 Shahab C, Miller M.  The introduction of meningococcal conjugate A vaccines into African countries within the meningitis belt. (submitted).

 Miller M, Shahab C,.  A review of the economics of meningococal meningitis control.   Pharmacoeconomics (in press).

 Simonsen L, Parvathi Myer P, Miller M.  Health disparities in severe outcomes of diarrheal disease in the US:  identifying high risk groups targeted for rotavirus vaccination. (submitted).

  Abstracts/letters

Doshi SJ, Miller M, Schultz LJ, Strikas R, Williams W.  Patterns of influenza and pneumococcal vaccination amongst women in the US. Abstract of the 30th National Immunization Conference, Washington DC, April 1996.

Miller M,  Strikas R, Williams W.  Vaccination against influenza amongst high risk persons in the US population.  Abstracts of the Third Meeting of the Options to Control Influenza, Cairns, Australia, May 4-7, 1996.

 

Doshi SJ, Schultz LJ, Miller MA.  Racial differences in influenza vaccination coverage among US women >65 years, 1993. Abstracts of the Third Meeting of the Options to Control Influenza, Cairns, Australia, May 4-7, 1996.

 

Miller M, Williams W, Redd S.  Measles in the adult US population.  Abstracts of the Thirty Sixth Annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 17-20, 1996.

 

Whitney CG, Levine O, Robertson R, Miller M,  Schwartz B.  Cost-effectiveness of haemophilus influenzae type b conjugate immunization in developing countries. Abstracts of the Thirty Sixth Annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, September 17-20, 1996.

 

Doshi SJ, Miller MA, Schultz LJ, Lobel HO.  Vaccination rates among US travelers to developing countries, 1986-1991.  Abstracts of the 124th Annual Meeting of the American Public Health Association, New York City, November, 1996.

 

Legros J, Miller MA, Strikas R, Williams WW.  Influenza and pneumococcal vaccination levels and receipt of other preventive health services. Abstracts of the 124th Annual Meeting of the American Public Health Association, New York City, November, 1996.

 

Sutter R, Strebel P, Miller M, Hadler S.  Epidemiology of vaccine-associated paralytic poliomyelitis in the United States (letter). Journal of the American Medical Association (in press).

 

Silber JL, Strikas RA, Young G, Miller M, Paul S, Cetron MS, Breiman RF.  Measuring the impact of a multifaceted pneumococcal vaccination program through an annual telephone survey.  Abstract presented at the 35th Annual Meeting of the Infectious Diseases Society of America, SanFrancisco, September 13th -16th.

 

Miller MA , Wenger J, Rosenstien N, Perkins B.  Evaluation of Meningococcal Meningitis Control Strategies for the Meningitis Belt in Africa. Abstracts of the Thirty Seventh Annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto September 28th -October 2nd, 1997.

 

Miller MA, Schwartz B.  Assessment of Pneumococcal Conjugate Vaccine Incorporation into the Global Expanded Programme on Immunizations. Abstracts of the Thirty Seventh Annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto September 28th -October 2nd, 1997.

 

Miller MA, Redd SC, Hadler S, Hinman AR.  Economic Benefits of Global Measles Eradication for the United States. Abstracts of the Thirty Seventh Annual meeting of the Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto September 28th -October 2nd, 1997.

Singleton JA, Miller M, Strikas RA, Williams WW.  Influenza vaccination of person with chronic cardiovascular disease, United States, 1989 through 1994.  Abstracts of the 12^th National Conference on Chronic Disease Prevention, Washington DC, December 3-5^th  1997.

 

Miller MA.  Hidden costs of unsafe injections.  In World Health Organization/Global Programme for Vaccines and Immunization.  Technical network for logistics in health Copenhagen consultation ’98.  Geneva, 1998.

 

Miller M, Widdus R, McCann L. New vaccine adoption into national immunizations programs.  Nordic Vaccine Meeting, Helsinki, October 7-8, 1998.

 

Miller M, Strebel P, Olivé JM.  More on measles (letter). Public Health Reports. 1999;114:4-5.

 

Miller M. Progress of vaccine adoption into national immunizations programs.  Clinical Microbiology and Infection.  1999;5:44.

Lieu T, Ray GT, Black S, Shinefield H, Butler J, Miller M.  Cost-effectiveness of Pneumococcal Vaccine. JAMA 2000 Jul 26;284(4):440-441.

 

Miller M.  Adoption of Global Public Health Goods: The Case of Vaccines.  Published in the proceedings of the World Medical Association Conference, Edinboro, October, 2000.

 

Walker D, Fox-Rushby F, Sanderson C, Cutts F, Miller M. How useful are existing models for predicting the cost-effectiveness of introducing new vaccines?  International Health Economics Association Conference, York, July 2001.

Parashar U, Hummelman E, Bresee J, Miller MA, Glass R.  An Estimate of the Global Mortality from Rotavirus Disease in Children.  Vaccines for Enteric Diseases VED 2001, Tampere, Finland, September 12-14, Finland.

Simonsen L, Reichert T, Miller MA.  Effect of influenza vaccination in the United States:  Prevention of mortality among the elderly.1^st European Influenza Conference, Malta October, 2002).

Reichert T, Simonsen L, Miller MA.  The virtues of antigenic sin. 1st European Influenza Conference, Malta October, 2002).

Reichert T, Simonsen L, Sturke R, Depinay JM, Miller MA.  Estimating the global burden of mortality due to influenza:  building the tools.  1st European Influenza Conference, Malta October, 2002).

Simonsen L, Blackwelder, WC, Reichert TA, Miller MA.  Estimating deaths due to influenza and respiratory syncytial virus (letter). JAMA. 289 (19): 2499-2500.

C Viboud, A Flahault, M Miller. Patterns of synchrony and coherence in influenza epidemics. Center for Discrete Mathematics and Theoretical Computer Science, Working Group on Spatio-Temporal and Network Modeling of Diseases, Rutgers University, USA, 2003, Apr 22-26.

Viboud C, Miller M. Space and time correlation of influenza epidemics in the United States:1968-1998. Options for the control of influenza V, Okinawa, Japan, 2003, Oct 7-11.

 

Rachel Nugent, Ph.D.
Program Officer, Division of International Training and Research

Anderson, C. Leigh, Laura Locker, and Rachel A. Nugent, 2002, “Microcredit, Social Capital, and Common Pool Resources,” World Development, vol 30(1), January, 95-105.

Nugent, Rachel A., “Contributions and constraints from agriculture in achieving a nutrition strategy to prevent chronic disease,” Asia Pacific Journal of Clinical Nutrition, 2002; 11 Supp 9: S767-71. Dolsak, N. and E. Ostrom (eds.), The Commons in the New Millenium, MIT Press, 2003.

Book Chapter

Anderson, C. Leigh, Laura Locker, and Rachel A. Nugent, “A Framework for Analyzing the Political, Social and Human Capital Effects of Microcredit on Common-Pool Resources,” in The Commons in the New Millenium: Challenges and Adaptation, Nives Dolsak and Elinor Ostrom (eds.), MIT Press, in press.

 

Joshua P. Rosenthal, Ph.D.
Deputy Director, Division of International Training and Research

Kotanen, J.P. and J.P. Rosenthal (2001) Tolerating herbivory: does the plant care if the animal has a backbone? Evolutionary Ecology 14: 537-549

Rosenthal J.P., D. Beck, A. Bhat, J. Biswas, L. Brady, K. Bridbord, S. Collins, G. Cragg, J. Edwards, A. Fairfield, M. Gottlieb, L. Gschwind, Y. Hallock, R. Hawks, R. Hegyeli, G. Johnson, G. Keusch, E. Lyons, R. Miller, J. Rodman, J. Roskoski, D. Siegel-Causey. (2000). Combining high-risk science with ambitious social and economic goals. Pharmaceutical Biology 37(Supplement): 6-21 

Edited Volumes

Rosenthal, J.P. (ed.) (1999) Drug Discovery, Economic Development and Conservation, Pharmaceutical Biology 37:Supplement

Grifo, F. and J. Rosenthal (eds.) (1997) Biodiversity and Human Health. Island Press, 379 pp. Washington D.C. 

Book Chapters and Proceedings

Rosenthal, J. P. and T. Preszler (2002) Biodiversity in biomedical research. In: Aguirre, A. A., R. S. Ostfeld, C. A. House, G. M. Tabor and M. C. Pearl (eds.).  2001.  Conservation Medicine: Ecological Health in Practice. Oxford University Press, New York  

Dirzo, R., R. Lindigi,  J. Rosenthal (2001)  Plantas cultivadas y sus parientes silvestres: sistemas modelo para estudios de Ecologia Quimica. In: Anaya, A. (ed.) Relaciones Quimicas entre Organismos: Aspectos Basicos y Perspectivas de su Aplicacion, Mexico D.F. 

Opinion/Editorial

Joshua Rosenthal et al. (16 co-authors), (2000) Curtains fell on hopes of legal bioprospecting. Nature Magazine, [Correspondence] Feb. 2002. 

Joshua Rosenthal (1999).  At Issue: Is it economically viable to look for natural cures in rain forests?  CQ Researcher (Congressional Quarterly) June 11, 1999. V 9, No. 22, P. 513. 

 

David Smith, Ph.D.
Research Scientist, Division of International Epidemiology and Population Studies

DL Smith, AD Harris, JA Johnson, EK Silbergeld, & JG Morris, Jr. 2002.  Antibiotic use in animals has an early but important impact on antibiotic resistant in human commensal microbes. Proceedings of the National Academy of Sciences, USA 99(9): 6434-6439. 

DL Smith, B Lucey, JE Childs & LA Real. 2002. Predicting the spatial  dynamics of rabies dynamics on heterogeneous landscapes. Proceedings of  the National Academy of Sciences, USA 99(6): 3668-3672. 

AD Harris, DL Smith, JA Johnson, DD Bradham, & MC Roghmann. 2002. Risk  factors for Imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clinical Infectious Diseases 34:340-345. 

BT Lucey,  CA Russell,  D Smith, ML Wilson, A Long, LA Waller, JE Childs, & LA Real, Spatiotemporal analysis of epizootic raccoon rabies propagation in Connecticut, 1991-1995. Vector Borne and Zoonotic Diseases 2(2): 77-86. 

LA Waller, DL Smith, JE Childs, & LA Real. Monte Carlo assessments of goodness-of-fit for ecological simulation models. To appear Ecological Modeling.

 

Cecile Viboud, Ph.D.
Research Fellow, Division of International Epidemiology and Population Studies

Viboud C., Boëlle PY, Cauchemez S, Lavenu A,  Valleron AJ, Flahault A., Carrat F. Risk factors of influenza transmission in households (In review).

Viboud C., Boëlle P-Y., Pakdaman KP., Valleron A-J., Flahault A. Geographical coherence of influenza epidemics in the USA, France and Australia: 1972-97 (In review).

Viboud C., Pakdaman K., Boëlle P-Y., Myers M., Wilson M. L., Valleron A-J., Flahault A. Association of influenza epidemics with global climate variability. (In review).

Viboud C., Boëlle P-Y., Carrat F., Valleron A-J., Flahault A. Prediction of the geographical spread of influenza epidemics by the method of analogues. (In revision).

Bourcier T, Viboud C, Cohen C, Thomas F, Bury T, Cadiot L, Mestre O, Flahault A, Borderie V, Laroche L  Effects of air pollution and climatic conditions on the frequency of ophthalmologic emergency examinations. British Journal of Ophtalmology, 2003, in Press.

Etienney I., Beaugerie L., Viboud C., Flahault A. Non steroidal anti-inflammatory drugs (NSAIDS) as a risk factor of acute diarrhea: a case-crossover study. GUT, 2003; 52(2):260-263.

Viboud C., Boëlle P-Y., Kelly J., Schlingmann J., Auquier A., Roujeau J-C., Flahault A. Comparison of the statistical efficiency of case-control and case-crossover designs: application to severe cutaneous adverse reactions J. Clin. Epidemiol. 2001 Dec ; 54(12):1218-1227.

Viboud C., Ke Jinyun. Diffusion of influenza epidemics and linguistic innovations in small-world networks of age-structured populations. In Santa Fe Institute ed. Complex System Summer School, Santa Fe, 2001.

Fagot J-P., Mockenhaupt M., Bouwes-Bavinck J-N., Naldi L., Viboud C., Roujeau J-C. Nevirapine use and the risk of SJS or TEN. Preliminary results of an european case-control study. AIDS, 2001 Sep 28;15(14):1843-8.

Hanslik T., Viboud C., Flahault A. Hepatitis B vaccination and the risk of multiple sclerosis, N Engl J Med. 2001 Jun 7;344(23):1793-4.

Hanslik T., Viboud C., Chadenat M-L., Jubault V., Prinseau J. Vitamin K in anticoagulation therapy. Lancet 2001 Mar 3;357(9257):718

Letrilliart L., Viboud C., Boëlle P-Y., Vibert JF., Valleron AJ., Flahault A. Unconstrained automatic coding of encounter assessments from natural language in general medicine.  Proc AMIA Symp. 2000; 487-91.